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Abstract
Background: Kawasaki disease results from an abnormal immunological response to one or more infectious triggers. We
hypothesised that heritable differences in immune responses in Kawasaki disease-affected children and their families would
result in different epidemiological patterns of other immune-related conditions. We investigated whether hospitalisation for
infection and asthma/allergy were different in Kawasaki disease-affected children and their relatives.
Methods/Major Findings: We used Western Australian population-linked health data from live births (1970–2006) to
compare patterns of hospital admissions in Kawasaki disease cases, age- and sex-matched controls, and their relatives. There
were 295 Kawasaki disease cases and 598 age- and sex-matched controls, with 1,636 and 3,780 relatives, respectively.
Compared to controls, cases were more likely to have been admitted at least once with an infection (cases, 150 admissions
(50.8%) vs controls, 210 admissions (35.1%); odds ratio (OR)=1.9, 95% confidence interval (CI) 1.4–2.6, P=7.2610
26), and
with asthma/allergy (cases, 49 admissions (16.6%) vs controls, 42 admissions (7.0%); OR=2.6, 95% CI 1.7–4.2, P=1.3610
25).
Cases also had more admissions per person with infection (cases, median 2 admissions, 95% CI 1–5, vs controls, median 1
admission, 95% CI 1–4, P=1.09610
25). The risk of admission with infection was higher in the first degree relatives of
Kawasaki disease cases compared to those of controls, but the differences were not significant.
Conclusion: Differences in the immune phenotype of children who develop Kawasaki disease may influence the severity of
other immune-related conditions, with some similar patterns observed in relatives. These data suggest the influence of
shared heritable factors in these families.
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Introduction
Kawasaki disease (KD) is an acute febrile vasculitis of unknown
aetiology that predominantly affects infants and pre-school
children. Probably uniquely amongst childhood illnesses, KD
damages the coronary arteries and is the leading cause of pediatric
acquired heart disease in developed countries.[1,2] The consensus
is that KD is triggered by to one (or more) widely distributed but as
yet unidentified infectious agent(s) that precipitate an abnormal
immunological response in genetically susceptible individuals.[2,3]
There isa significantgenetic contributionto KDsusceptibility.[4]
Epidemiological data indicate that KD segregates in families, with
theparentsofchildrenwithKDsignificantlymorelikelytohavehad
the disease themselves in childhood.[5] The heritability (ls)o fK D
in the Japanese is 6–10,[6] and a similar value is suggested in
Koreans (Burgner D, unpublished observations); no analogous data
are reported from other populations. The incidence of KD in
Japanese Americans born in Hawaii is higher than that reported in
Japan and over 10 times greater than that in US Caucasians.[7]
Genomic data, both from candidate gene and more recently from
genome-wide linkage[8] and association analyses,[9,10,11] have
identified variants, particularly in immune- and cardiovascular-
related genes, that may contribute to KD susceptibility.
We hypothesised that heritable differences in immune responses
in Kawasaki disease would influence the frequency and severity of
other immune-related conditions. We investigated whether
children with KD and their relatives had different epidemiological
patterns of infectious diseases, asthma/allergy and autoimmune
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28004diseases using total linked population data, with hospital admission
as a measure of disease severity.
Methods
Objectives
Given the likely immunogenetic contribution to KD suscepti-
bility, we hypothesised that diseases for which immune function is
important in determining susceptibility and severity might show
distinct epidemiological patterns in KD-affected children and their
biological relatives.
Setting
Western Australia (WA, total population ,2.29 million) has a
unique resource of linked population health data (The WA Data
Linkage System, WADLS), which integrates complete population
health (including hospital admissions) and other key demographic
data from 1969 onwards.[12] The WA Family Connections
Genealogical Project has used this resource to develop a system of
linkages within WALDS representing genealogical relationships
for residents of WA.[13] We used these resources to compare the
epidemiology of hospital admissions with infectious diseases,
asthma/allergy, and autoimmune diseases in all KD cases
diagnosed in Western Australia between 1974 and 2006, and
their relatives, with data from matched non-KD children and their
families.
Participants
We analysed data from WADLS, which comprises linked data
from statutory collections, including the WA Registry of Births,
Deaths and Marriages, and the Hospital Admissions Data
Collection (HMDC), from 1970 onwards.[14] These datasets have
been extensively validated previously.[12,15,16] A cohort of KD
cases and controls was selected from the WADLS by firstly
identifying individuals whose births were recorded in the WA
Birth Registry between 1974 and 2006. From this group, all
available KD cases were selected using hospital admission records
(from the HMDC), using a discharge diagnostic coding of KD (the
International Classification of Diseases (ICD) version 10 code,
M30.3, or the ICD version 9 code, 446.1). Two siblings with KD
were identified; one was excluded from analyses to maintain an
unrelated case population. Age- and sex-matched controls for the
KD cases were selected from those individuals with neither a
diagnosis of KD nor a history of KD in their 1
st,2
nd or 3
rd degree
relatives, according to the HMDC, with a ratio of approximately
two controls to each KD case. All cases and controls were
unrelated to each other to within three degrees. Genealogical
information for cases and controls, available through the linked
Family Connections Project database,[13] was used to identify all
1
st,2
nd and 3
rd degree relatives of cases and controls. In total 1,636
relatives of KD cases and 3,780 relatives of controls were
identified. Admission to hospital was used as a marker of infection
severity.[17,18] Birth, death and hospital admission data for each
individual were extracted from subsets of the Birth Registry (1974–
2006), Death Registry (1970–2006) and HMDC (1970–2006)
databases. Data on Aboriginality and self-determined ethnicity
were not readily available. Individuals born outside of WA, and
therefore not recorded on the Birth Registry, were not included.
Classification of hospital admissions
We initially analysed the data with respect to seven disease
groups; cardiovascular disease, asthma/allergy, autoimmune
diseases, infectious diseases, Crohn disease, ulcerative colitis and
psoriasis. The ICD codes used to define each of the broad disease
groups were defined a priori (Supplementary Table S1). ICD codes
for infectious disease admissions were grouped into clinically
meaningful categories using the Clinical Classification Software
(CCS).[19] All ICD codes for hospital admissions were standard-
ised to ICD Version 10.5 codes prior to analysis. We calculated the
incidence of each disease group (censored after the first admission)
and the total number of admissions per individual in each of the
four study populations (KD cases, non-KD controls, KD case
relatives, non-KD control relatives). The numbers of admissions
with Crohn disease, psoriasis and ulcerative colitis were too low to
permit further analysis. Analysis of cardiovascular disease
admissions was restricted to relatives’ data only, as cardiovascular
disease admissions in cases and controls were only related to
investigation of cardiovascular sequelae of KD.
Statistical methods
Hospital admission data for infectious diseases, asthma/allergy,
and autoimmune diseases in KD cases and controls were initially
analysed by comparing the incidence of diagnoses in each disease
group between cases and controls, using a Monte Carlo method
for sparse data implemented in the CLUMP software v2.3.[20]
The Mann-Whitney test was used to compare the age at admission
and the number of admissions per person for each disease group in
KD cases and controls.
The hospital admission data for the relatives of KD cases and
controls were analysed using generalised linear mixed models
(GLMMs) to model the effects of covariates on disease-related
variables and therefore account for the correlation between related
individuals. The correlation between outcomes from related
individuals must be accounted for in order to obtain appropriate
inferences about the fixed effects (or exposures); the standard
errors of the fixed effect estimates will be incorrect if the
correlation is not modelled. The GLMMs analyses utilised the
glmmPQL function in the statistical analysis package, R
v2.11.0,[21] and accounted for family groups by using the family
ID to describe a contribution to the random effects. The incidence
of each disease was analysed as a binomial outcome, while the age-
at-onset and number of admissions per person were analysed as
continuous outcomes. Age-at-onset outcomes were analysed under
a Gaussian model, with the asthma/allergy, and infectious disease
outcomes being log-transformed prior to analysis. The numbers of
admissions per person for all diseases were analysed under a
Poisson model. For each model, a covariate was included to adjust
for the relationship of an individual to a KD case. Additional
covariates for each model were selected by initially including both
(where appropriate) of the covariates sex and age in the analysis,
and removing those not significantly associated with the outcome
in a step-wise manner. Using a binary covariate indicating the
presence or absence of a relative of any degree (1
st,2
nd or 3
rd) with
KD, analyses were performed on the population of all relatives of
KD cases and controls, and on male and female relatives
separately. Using a factored covariate indicating the degree of
relatedness of an individual to a KD case (0, 1, 2 or 3), analyses
were performed on a subset of the population of all relatives. This
subset included all 3,780 control relatives plus a reduced set of
1,228 KD case relatives, obtained by excluding the pedigrees of
cases with incomplete or inconsistent family data. With this subset
we were able to calculate the degree of relatedness between cases
and their relatives using R’s Kinship package (http://cran.r-
project.org/web/packages/kinship/index.html).
The incidence of diseases in the relatives of KD cases was also
investigated by calculating the relative risk (RR) of each of the
disease groups in the relatives of KD cases compared to the
relatives of controls, using a random-effects Cox proportional
Hospitalisations in Kawasaki Disease Families
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1,094 KD case relatives and 2,232 control relatives from pedigrees
satisfying all of the criteria of the familycheck function in R’s Kinship
package. Analyses were performed using the coxme function of the
Kinship package. The number of 3
rd degree relatives of KD cases
born in WA (and therefore on whom childhood admission data
were available) was too small to permit detailed analysis, which
was therefore restricted to 1
st and 2
nd degree relatives of KD cases
and controls.
Ethics
This study was approved by the University of Western Australia
Human Research Ethics Committee and the Western Australian
Department of Health Human Research Ethics Committee.
Results
Infectious disease hospital admissions
There were 295 KD cases and 598 non-KD age- and sex-
matched controls, with 1,636 and 3,780 relatives, respectively. The
median age of KD diagnosis was 3 years (95% confidence interval
(CI) 0–9 years). The KD case group had a higher proportion of
individuals with at least one infectious disease admission (150/295,
50.8%) than the control group (210/598, 35.1%); odds ratio
(OR)=1.9, 95% CI 1.4–2.6, P=7.2610
26 (Table 1, Supplemen-
tary Figure S1). The number of infectious disease admissions per
person was also higher in KD cases (median of 2 admissions, 95%
CI 1–5) than in controls (median of 1 admission, 95% CI 1–4),
P=1.09610
25 (Table 1). Most infectious disease admissions
occurred prior to 10 years of age in KD cases and controls
(Figure 1). The majority of infectious disease admissions in cases
(94% of total) occurred prior to the diagnosis of KD. To account
for the possibility that infectious disease admissions in KD cases
may have been inflated by admissions during the KD illness but
prior to KD diagnosis, 19 infectious disease admissions occurring
two weeks prior to KD admission were excluded. The proportion
of individuals admitted at least once with an infectious disease
remained significantly higher in KD cases than in controls
(OR=1.5, 95% CI 1.1–2.0, P=0.01) (Table 1). The number of
admissions per person for infectious diseases also remained
significantly higher in KD cases following adjustment for the two
weeks prior admissions (P=5.50610
26) (Table 2, Figure 1). There
was no significant difference between KD cases and controls in the
age of the first hospital admission with any diagnostic grouping
(Table 1).
The frequencies of clinical diagnostic categories of infectious
diseases showed that admission with clinically diagnosed ‘viral
infection’ (CCS code 7) was significantly more common in KD
cases (61 of 434 total infectious disease admissions, 14.1%) than in
non-KD controls (35/463, 7.6%), P,1610
26 (Supplementary
Table S2). ‘Skin and subcutaneous infection’ (CCS code 21)
admissions were less common in KD cases (21, 4.8%) than controls
(35, 7.6%), although the differences were not significant. Similar
patterns of infectious disease admissions (i.e. increased viral
infections, decreased skin and subcutaneous infections) were
observed in the relatives of KD cases compared to the non-KD
relative groups, although differences were not significant. Other
clinical infection categories were largely similar in KD cases and
controls and their relatives (Supplementary Table S2).
Asthma/allergy hospital admissions
KD cases were more likely to have been admitted at least once
with asthma/allergy (KD cases 49 admissions (16.6%) vs controls
42 admissions (7.0%); OR=2.6, 95% CI 1.7–4.2, P=1.3610
25
(Table 2). Asthma accounted for 57 of the 90 admissions (63.3% of
total), and allergic disease for the remainder (Supplementary Table
S3). The majority of admissions for asthma/allergy occurred
before the age of 10 years (Figure 2). The number of admissions
per person for asthma/allergy did not significantly differ between
KD cases and controls (Table 2).
The generalized linear mixed models (GLMM) analysis showed
no significant overall differences between the relatives of the KD
cases and controls in incidence, age at onset or number of
admissions per person for any disease group (Table 3). No
significant associations were observed when analyses were
stratified by gender (data not shown). Second degree relatives of
KD cases had more admissions per person with asthma/allergy
(Coefficient =1.11, 95% CI 0.73–1.49, P,0.0001) (Table 4). The
results of random-effects Cox proportional hazards model analyses
of disease incidence in case and control relatives were consistent
with GLMM results; the risk of hospital admission for infectious
disease was approximately three-fold higher in 1
st degree relatives
of KD cases compared to 1
st degree relatives of controls, although
this was not statistically significant (data not shown).
Discussion
This is the first study using population-linked data to investigate
the incidence of infection and immune-related diseases in KD
patients and their relatives. We analysed the unique linked health
data resources available in WA and used hospital admission as a
marker of illness severity.[17] Patterns of infection and asthma/
allergy differed significantly between KD cases and controls.
Children with KD were more likely to be admitted to hospital for
Table 1. Population descriptives and comparison of the incidence of diseases in KD cases and controls and their relatives.
KD cases, n(%) Controls, n(%)
Odds ratio
(95% CI)
Chi-square
P value
Relatives of KD
cases, n(%)
Relatives of
controls, n(%)
Cohort 295 (100%) 598 (100%) 1636 (100%) 3780 (100%)
Male 183 (62.0%) 376 (62.9%) 834 (51.0%) 1937 (51.2%)
KD 295 (100%) 0 (0%) 0 (0%) 0 (0%)
Infectious diseases 150 (50.8%) 210 (35.1%) 1.9 (1.4, 2.6) 7.2610
26 { 561 (34.3%) 1379 (36.5%)
Infectious diseases (adjusted)* 131 (44.4%) 210 (35.1%) 1.5 (1.1, 2.0) 0.01
{ --
Asthma/allergy 49 (16.6%) 42 (7.0%) 2.6 (1.7, 4.2) 1.3610
25 { 151 (9.2%) 332 (8.8%)
Autoimmune diseases 8 (2.7%) 7 (1.2%) 2.4 (0.7, 7.7) 0.10 37 (2.3%) 70 (1.9%)
{P,0.05;
{ P,0.001; * admissions #2 weeks prior to KD diagnosis excluded.
doi:10.1371/journal.pone.0028004.t001
Hospitalisations in Kawasaki Disease Families
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e28004infectious diseases and asthma/allergy and had more infectious
disease admissions per person than non-KD controls. The
majority of these infectious and allergy/asthma admissions
occurred prior to KD and are therefore unlikely to reflect immune
dysfunction resulting from KD itself. Relatives of KD children also
had more hospital admissions for asthma/allergy and for infection,
compared with control relatives matched for degree of relatedness,
although the effect sizes were smaller. Admission diagnoses of viral
infections were more common, and skin and soft tissue infections
less common in KD children and their relatives compared to
control families. These data suggest that inherited immunological
differences and/or differing rates of immune maturation[22] in
KD patients may affect the epidemiologic patterns of other
immune-related conditions.
The incidence and the total number of infectious disease
admissions remained significantly increased in KD patients when
the admissions in the two weeks prior to the KD diagnosis were
excluded. Previous studies have shown that around the time of the
KD diagnosis, children often have symptoms of other infectious
diseases.[23] This partly reflects the diagnostic difficulties in KD,
where the differential diagnosis is broad and there is no diagnostic
test.[2] However there is also a high incidence of microbiologically
confirmed concurrent infections at the time of KD diagnosis;[24]
therefore exclusion of infectious admission in the two weeks prior
to the KD diagnosis may be overly conservative and is likely to
have underestimated the true effect size of infection-related
admissions in the KD group. Viral infections, which were
diagnosed clinically (the study period predates the introduction
of rapid viral diagnostics), are amongst the most common
concurrent infections at the time of KD diagnosis[24] and
accounted for some of the overall increased infectious disease
admissions in KD patients and their families. It is possible that the
immunogenetic determinants of KD also alter the susceptibility to
(or the severity of) viral infection. A viral trigger may be involved
in initiating the abnormal immune response in KD.[25]
Children with KD were more likely to be admitted to hospital
with allergy and asthma, with the majority of these admissions
occurring before the KD admission. This suggests that a distinct
immune phenotype may be associated with an increased risk of
both KD and asthma/allergy. In acute KD there is sustained
neutrophil activation, with increased release of human neutrophil
elastase and matrix metalloproteinases,[26] and similar patterns
may be important in childhood asthma.[27] Immunogenetic
variation in the innate immune response may contribute to the
shared risk of KD and infection and/or asthma/allergy. For
example common functional variants in the gene for mannose
binding lectin (MBL), a key complement-like constituent of innate
immune defence, have been associated with susceptibility to
KD,[28] and also coronary artery damage.[29] A role for MBL
variants in susceptibility to certain infections, and to asthma and
atopy has been reported, but data are inconsistent.[30] The
available data suggest that KD is unlikely to be triggered by
common allergens.[31]
The balance of T helper (Th) 1 and 2 responses is perturbed in
acute KD,[32,33,34] and during the sub-acute phase there is a
Th2 predominance.[35] Persistent immunological changes are
also observed in the weeks following KD and persist for some
months. These changes include a selective and prolonged T cell
unresponsiveness to activation via the T cell antigen receptor CD3
and an incomplete responsiveness to measles-mumps-rubella
vaccination.[22] A number of studies report increased asthma
and allergy following KD, including an increased risk of atopic
dermatitis suggested in US children.[36] A Japanese epidemio-
logical survey reported that KD-affected children were almost
twice as likely to develop dermatitis and/or allergic rhinitis and
more likely to have a family history of allergy than non-KD
controls.[37] Similar findings are reported from a sibling study
from Singapore; KD-affected children had more allergy and
asthma following KD than their non-KD affected siblings.[38]
Table 2. Comparison of age at onset and number of hospital admissions per person, of diseases in KD cases (n=295) and controls
(n=598).
Age at onset Hospital admissions per person
KD cases, median
years (95% CI)
Controls, median
years (95% CI)
Mann-Whitney
P value
KD cases, median
years (95% CI)
Controls, median
years (95% CI)
Mann-
Whitney P
value
Infectious diseases 1 (0, 8) 1 (0, 12) 0.31 2 (1, 5) 1 (1, 4) 1.09610
25 {
Infectious diseases (adjusted)* 1 (0, 9) 1 (0, 12) 0.38 2 (1, 5) 1 (1, 4) 5.50610
26 {
Asthma/allergy 2 (0, 8) 2 (0, 14) 0.46 1 (1, 4.6) 1 (1, 4) 0.81
Autoimmune diseases 4.5 (0.4, 8.6) 9 (1.9, 15.7) 0.12 1 (1, 1) 1 (1, 3.8) 0.35
{P,0.001; *admissions #2 weeks prior to KD diagnosis excluded.
doi:10.1371/journal.pone.0028004.t002
Figure 1. Age at hospital admission with infectious diseases in
KD cases and controls. KD case admissions coded as infectious
disease up to 2 weeks prior to KD diagnosis have been excluded.
doi:10.1371/journal.pone.0028004.g001
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KD, as well as an underlying susceptibility to both KD and
asthma/allergy; the investigation of children following the KD
illness does not differentiate between the two possibilities. In our
study the majority of infectious and allergy/asthma admissions in
KD patients occurred prior to the KD illness, suggesting that there
may be underlying immunological differences in this population
and that the increased admissions do not reflect perturbation of
immune function due to the KD itself.
Inflammatory and autoimmune diseases show clustering in
epidemiologic studies, with shared pathophysiology,[39] and
increasing evidence of common genetic determinants.[40,41] It
has been suggested that environmental insults in early life may
lead to broad patterns of immune dysfunction and clustering of
conditions characterised by immune dysfunction.[42] Investiga-
tion of common pathogenic pathways may therefore be informa-
tive about KD and other inflammatory diseases where the
aetiology and pathogenesis remain incompletely understood.
The strengths of our analysis include the novelty of the
approach, the use of population data and the linked family data,
which has been extensively validated in previous studies.[12] We
excluded individuals that were born outside of WA, for whom
childhood admission data were unavailable. As the diagnosis of
KD is made largely on a constellation of non-specific clinical
features that appear sequentially, the syndrome is often initially
misdiagnosed as infectious and patients may be admitted to
hospital more than once during the KD illness. We therefore
excluded all admissions with infectious disease codings in the two
weeks preceding the KD-related admission, to reduce likely
inflation of infectious disease-related admissions in KD patients
that were part of the KD diagnostic process.
We acknowledge some limitations to the study. The use of
linked anonymised population data meant that the diagnosis of
KD could not be confirmed on an individual case basis from the
clinical notes. Previous studies involving KD patients in WA[9]
indicate that the diagnosis of KD is made in accordance with the
internationally accepted case definition (Burgner D, unpublished
observations).[2] We are therefore confident that the KD coding is
likely to be specific and any mis-diagnoses would not introduce
systematic bias. Data on Aboriginal status were not readily
available for the current analysis. Approximately 3.8% of the
population of WA is Aboriginal, and Aboriginal children have a
higher rate of hospitalisations for many infectious diseases than
non-Aboriginal children.[17] Interestingly KD appears relatively
rare in Aboriginal children; in the only published Australian KD
epidemiology, only 2 of 139 children identified by active
surveillance were Aboriginal.[43] The analyses are therefore
unlikely to be biased by Aboriginal status. We used hospital
admission as a proxy for disease severity, as previously,[17]
because data for primary care and emergency department
attendances were not available as part of the WADLS. Moreover,
health-seeking behaviour differs between families and may not
necessarily reflect illness severity. This may be an important
consideration in families of children who have had KD, as the
diagnosis results in considerable parental anxiety,[44] and medical
consultations in ambulatory care may be increased. Analysis using
more severe phenotypes is relatively conservative, but gives greater
confidence in the validity of the findings. Clinical criteria for
hospitalisation are likely to be uniform across WA pediatric
centres. We are unable to comment on the epidemiologic patterns
of less severe manifestations of immune-related illnesses, which
account for the majority of pediatric morbidity. This is particularly
true of mild infections and allergic conditions, as well as diseases
such as psoriasis, which rarely require hospitalisation. Investiga-
tion of less severe, non-hospitalised illness would require
prospective surveillance and is not amenable to population-based
linkage analysis. Western Australia has a largely Caucasian
population (detailed ethnicity data were not available for this
analysis),[17] and the incidence of KD is therefore lower than in
high incidence Asian countries. Further studies in high incidence
populations are warranted to confirm the epidemiological patterns
described. As the clinical phenotype and epidemiology of KD is
Figure 2. Age at hospital admission with asthma/allergy in KD
cases and controls.
doi:10.1371/journal.pone.0028004.g002
Table 3. Generalized linear mixed model analyses of the incidence, age at onset, and number of hospital admissions per person of
diseases in relatives of KD cases and controls, clustering by family.
Incidence Age at onset (years) Hospital admissions per person
OR (95% CI) P value Coefficient (95% CI) P value Coefficient (95% CI) P value
Asthma/allergy
1 1.11 (1.11, 0.12) 0.35 1.12 (21.16, 1.44) 0.40 0.13 (20.09, 0.34) 0.25
Autoimmune diseases
# 1.23 (1.22, 1.23) 0.38 4.87 (4.26, 5.47) 0.13 20.21 (20.48, 0.05) 0.12
Infectious diseases
1 1.06 (1.05, 1.06) 0.49 21.01 (21.17, 1.15) 0.91 0.02 (20.10, 0.13) 0.76
Results given are for a binary term indicating the presence or absence of a relative with KD.
1The asthma/allergy, and infectious disease age at onset outcomes were adjusted for sex;
# The autoimmune disease incidence outcome was adjusted for sex and age
in 2008. The autoimmune disease number of hospital admissions per person outcome was adjusted for age in 2008.
doi:10.1371/journal.pone.0028004.t003
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morbidities will be present in other populations, reflecting shared
underlying heritable mechanisms. Finally our study lacked power
to comment with confidence on the incidence of cardiovascular
disease in relatives of KD patients. As KD is suggested to
predispose to accelerated atherosclerosis,[45,46] and atheroscle-
rosis-related outcomes may have genetic determinants,[47] this is
clearly of interest. The low incidence of autoimmune diseases in
children and their management without hospital admission limited
meaningful analyses of these conditions.
In summary, this is the first description of patterns of hospital
admission with common immune-related diseases in KD patients
and their families. We have shown that KD-affected children have
more admissions with infectious diseases and allergy/asthma, which
may reflect common host determinants and pervasive differences in
immune phenotype that result in differential disease risks.
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2u relatives of cases 5 (2.7%) 1.54 (1.52, 1.57) 0.43 22.92 (24.08, 21.76) 0.57 20.34 (21.24, 0.57) 0.47
3u relatives of cases 0 (0%) 2.46610
29 (0,‘)1 - - - -
Asthma/
allergy
1
Relatives of controls 332 (8.8%) Median =7 Median =1
1u relatives of cases 69 (8.1%) 0.99 (0.98, 0.99) 0.92 1.10 (21.28, 1.55) 0.59 20.10 (20.37, 0.16) 0.45
2u relatives of cases 16 (8.6%) 1.09 (1.09, 1.10) 0.73 1.41 (21.37, 2.72) 0.31 1.11 (0.73, 1.49) ,0.001
{
3u relatives of cases 2 (6.7%) 0.81 (0.79, 0.82) 0.75 26.07 (269.81, 1.89) 0.15 - -
Autoimmune
diseases
#
Relatives of controls 70 (1.8%) Median =24 Median =1
1u relatives of cases 19 (2.2%) 1.01 (1.00, 1.01) 0.98 3.88 (3.05, 4.71) 0.37 20.15 (20.47, 0.17) 0.40
2u relatives of cases 1 (0.5%) 0.48 (0.47, 0.49) 0.23 12.51 (9.28, 15.75) 0.43 - -
3u relatives of cases 1 (3.3%) 2.44 (2.38, 2.49) 0.22 217.49 (220.72, 214.25) 0.30 - -
Infectious
diseases
1
Relatives of controls 1379 (36.5%) Median =4 Median =1
1u relatives of cases 267 (31.2%) 0.95 (0.94, 0.95) 0.55 1.07 (21.13, 1.29) 0.48 20.09 (20.24, 0.05) 0.21
2u relatives of cases 60 (32.4%) 0.96 (0.96, 0.97) 0.83 1.24 (21.14, 1.76) 0.23 20.14 (20.42, 0.14) 0.34
3u relatives of cases 13 (43.3%) 1.41 (1.40, 1.43) 0.37 23.01 (28.15, 21.12) 0.03
{ 20.34 (20.99, 0.31) 0.30
Missing results indicate categories for which insufficient numbers were available for analysis.
*The CVD incidence outcome was adjusted for sex and age in 2008;
1 The asthma/allergy and infectious disease age at onset outcomes were adjusted for sex;
# The
autoimmune disease incidence outcome was adjusted for sex and age in 2008. The autoimmune disease number of hospital admissions per person outcome was
adjusted for age in 2008;
{ P,0.05.
doi:10.1371/journal.pone.0028004.t004
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